HeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular Algorithms

HeartSciences has secured a strategic partnership with the Icahn School of Medicine at Mount Sinai to commercialize advanced AI algorithms for early cardiovascular disease detection. By licensing intellectual property derived from tens of millions of curated ECG records, the company aims to transition these research-backed tools into market-ready solutions. This agreement facilitates a cloud-based, device-agnostic platform intended to identify heart disease across diverse global care settings, promising to reduce healthcare costs and improve patient outcomes through earlier intervention. The collaboration extends beyond simple licensing to include ongoing cooperation and access to de-identified data. This continuous exchange supports further research and the refinement of existing technologies, ensuring that the AI models remain at the cutting edge of medical science. The partnership highlights the critical role of large-scale, high-quality datasets in training effective AI systems, demonstrating how academic institutions can leverage their data infrastructure to drive innovation in digital health. This news is highly relevant to open data because it underscores the necessity of shared, de-identified datasets for advancing medical AI. While the commercial license restricts direct public access to the specific algorithms, the emphasis on de-identified data access for research illustrates the ecosystem required for robust AI development. It serves as a case study for how structured data sharing between healthcare providers and technology firms can accelerate scientific discovery and improve public health, balancing commercial interests with the scientific need for data-driven validation.

Source: dicardiology.com
Published on 2023-09-22

Group works to fight back against new FOIA revisions »

Open Data

Related news